![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Cadila Pharmaceuticals Limited Ankleshwar In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Venlafaxine hydrochloride, Alternative process, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-334 - Rev 00
This Chemical Type CEP, issued on April 20, 2016, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2119 associated with this CEP further emphasizes